false
OasisLMS
Catalog
SCCM Resource Library
Endocarditis and Cardiovascular Infections
Endocarditis and Cardiovascular Infections
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Megan Hicks, an assistant professor of anesthesiology, gave a presentation on the management of endocarditis and cardiovascular infections at Congress 2023. She discussed the current consensus guidelines, updates on antibiotic therapy, timing for surgical intervention, types of surgical intervention, and special considerations for certain populations. The mainstay of therapy for endocarditis is high dose, long duration beta-lactam antibiotic therapy. Surgical intervention is necessary for over 50% of patients, with specific indications including highly resistant or fastidious organisms, persistent bacteremia, and recurrent emboli. Repair is superior to replacement in most cases, and percutaneous therapies such as angiobac and laser lead extraction can be effective in certain situations.
Asset Subtitle
Cardiovascular, Infection, 2023
Asset Caption
Type: two-hour concurrent | Updates on Infectious Disease Guidelines in Critical Care (SessionID 1229708)
Meta Tag
Content Type
Presentation
Knowledge Area
Cardiovascular
Knowledge Area
Infection
Membership Level
Professional
Membership Level
Select
Tag
Cardiovascular
Tag
Infection
Year
2023
Keywords
endocarditis
antibiotic therapy
surgical intervention
consensus guidelines
percutaneous therapies
×
Please select your language
1
English